Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Inherited colorectal cancer syndromes increase the risk of contracting colorectal and other cancers. International guidelines recommend the identification of individuals with hereditary colorectal cancer and the supervision of asymptomatic individuals with a family history. However, detection of hereditary colorectal cancer is suboptimal. The prevalence of genetic counselling and testing for individuals with high genetic risk is low.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>To identify, characterize and summarize patient-targeted interventions on improving the uptake of colorectal cancer genetic evaluation for at-risk individuals and enhancing their informed decision making.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Design</h3><p>Systematic review.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Data Sources</h3><p>Six electronic databases (PubMed, CINAHL, Web of Science, Embase, PsycINFO, and Cochrane library) were searched to identify eligible clinical trials from each database's inception to March 25, 2020. The reference lists of the included studies and reviews were checked for additional articles.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Review Methods</h3><p>Studies were screened and independently appraised by two reviewers using the standardized critical appraisal checklist for randomized controlled trials and quasi-experimental studies from the Joanna Briggs Institute. The results were tabulated and reported in descriptive format.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Based on the inclusion criteria, 8 articles satisfied the inclusion criteria and were included. The studies examined patient-targeted intervention strategies related to risk assessment, education, and decision aids. Outcomes included (1) informed decisions regarding microsatellite instability testing, (2) informed decisions concerning genetic testing, (3) genetic counselling and testing. Most of the included studies revealed that interventions had positive effects on the uptake of colorectal cancer genetic evaluation for at-risk individuals and their informed decision making.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>There were few studies included in this review, and the results were inconsistent. Based on this review, the conclusion cannot be made that interventions for risk assessment, education, and decision aids have positive effects on the uptake of colorectal cancer genetic evaluation for at-risk individuals and their informed decision making. However, to our knowledge, this is the first systematic review to summarize the effectiveness of patient-targeted interventions to inform decision making and improve uptake of colorectal cancer genetic evaluation for at-risk individuals. This review provides important evidence for related topics. Future studies with rigorous designs are recommended. Nurses have a crucial role in personalized health care. The involvement of nurses in collaboration with all the stakeholders in the development, implementation and evaluation of cancer genetic screening programs to improve genetic referral of individual at risk.</p>

Interprestation of the key review points of human genetic resources application

Human genetic resources management of the Investigator-Initiated Clinical Trials

The application of McKinsey 7S model in management of human genetic resources in medical institutions

Strengthen the management of external provision of human genetic resource information in clinical trials

Protection of Human Rights in Clinical Trials

Analysis and research about the management of ethical post approval review in human subject research

Common Problems in the Ethical Review of Clinical Trial Protocols and the Countermeasures

Using human genetics to improve safety assessment of therapeutics

Human Subjects Protections in Clinical Drug Trials in China

"Informed Consent" Issue in Genetic Resource Research of Different Ethnic Groups in China

Practical exploration and research on improving the efficiency of ethical review

Ethical management of human clinical research in the age of big data

A review on genetic testing]

Common Review Comments on Investigator Initiated Study (IIS) Design and Considerations

Application status of pharmacogenomics in clinical researches of new drugs

A review of consensus statements, practice resources, standards and guidelines for clinical applications of next-generation sequencing technologies in the United States

Study on the Standardization of Initial Ethical Review of Drug Clinical Trial

Analysis and Evaluation of Personalized Medication Evidence Based on Pharmacogenetics

Construction and Application of Human Genetic Resources in the China Kadoorie Biobank.

The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy

Effectiveness of patient-targeted interventions to inform decision making and improve uptake of colorectal cancer genetic evaluation for at-risk individuals: A systematic review